Contribution: Industrial Research Assistance Program – Contributions to Firms
BioLytical Laboratories Inc.
$3,000,000.00
Development of Multiple Rapid Antigen Tests for Infectious Diseases
EF 2022-23 · 2022-06-01
Résumé
This project will support the firm’s development of 2 separate platforms for in vitro diagnostic test kits for infectious diseases that enable detection of disease antigens at industry leading speed. The project will also support the development of a number of new Point of Care (POC) or Self Test (SF) built upon the two new platforms, as well as the development of new processes for bioproduction and for automating the manufacture of the test kits
Ministère
Programme
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (lien de confiance élevée)
Bénéficiaire
Emplacement
Richmond|Richmond, British Columbia, Canada
Type de bénéficiaire
For-profit organization
Numéro d'entreprise
869859116
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Tel que publié
Agreement End Date
2025-03-31
Agreement Number
993817
Agreement Start Date
2022-06-01
Agreement Title
Development of Multiple Rapid Antigen Tests for Infectious Diseases
Agreement Title (French)
Mise au point de multiples tests rapides de détection d'antigènes de maladies infectieuses
Agreement Type
Contribution
Agreement Value
$3,000,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
This project will support the firm’s development of 2 separate platforms for in vitro diagnostic test kits for infectious diseases that enable detection of disease antigens at industry leading speed. The project will also support the development of a number of new Point of Care (POC) or Self Test (SF) built upon the two new platforms, as well as the development of new processes for bioproduction and for automating the manufacture of the test kits
Description (French)
Ce projet aidera l'entreprise à élaborer 2 plateformes distinctes pour les trousses de tests diagnostiques in vitro de maladies infectieuses par la détection des antigènes à la vitesse de l'industrie. Le projet soutiendra également la mise sur pied d'un certain nombre de nouveaux points de soins ou de tests autoadministrés basés sur les deux nouvelles plateformes, ainsi que le développement de nouveaux processus de bioproduction et d'automatisation de la fabrication des trousses.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Steveston--Richmond East
Federal Riding (French)
Steveston--Richmond-Est
Federal Riding Number
59031
NAICS Code
334512
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
869859116
Recipient City
Richmond|Richmond
Recipient Country
CA
Recipient Legal Name
BioLytical Laboratories Inc.
Recipient Postal Code
V6V 2A2
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2022-2023-Q2-993817
